Cone-Beam Computed Tomography

Adopt high-definition CBCT in your daily practice with the Allia™* platform to achieve better outcomes
At a glance

Precision

High-resolution images for detailed vision, real-time guidance for accuracy1.

Safety

Reduced radiation exposure for both patients and healthcare providers2.

Versatility

Wide range of interventional procedures for many clinical applications2.

Outcomes

Better performance and optimized procedures for improved patient outcomes1.

Pioneering CBCT

From conventional to AI-based CBCT, GE HealthCare creates a path to guide your activity through its evolution and complexity.

Not only a pioneer but also a leader in the field for almost three decades, GE HealthCare is continually innovating to provide you with solutions that meet the challenges and evolution of your interventional practice.

CBCT transcended

Optimize and fine-tune your activity for better patient outcomes and experience

Thanks to a whole range of options, achieve accuracy, safety, confidence, and effectiveness in your daily practice, for a better patient experience.
CleaRecon DL3,4

Entering the era of AI,
accessing higher image quality

CleaRecon DL is a deep learning technology designed to enhance the quality of CBCT images by removing streaks. It helps clinicians achieve clearer images, thus improving their trust in image interpretation when analyzing CBCT data. 

Feeling confident is crucial for accurate diagnosis and effective treatment planning. 
3D CT HD5

Optimizing diagnosis, surgical planning, interventional procedures, and treatment follow-up

3D CT HD5 is an option based on advanced algorithms that enhance soft tissue visualization, reduce noise, and minimize artifacts that may compromise visualization comfort. It provides high-quality imaging of internal body structures including vessels, bones, and soft tissues. This feature allows physicians to access high-quality images, to make informed decisions with confidence.
Motion Freeze6,7

Compensating for respiratory artifacts, minimizing radiation dose

Motion Freeze is a pioneering solution that significantly reduces motion artifacts caused by involuntary respiratory movements, thus enhancing the clarity and accuracy of CBCT images8. It allows for the correction of motion artifacts in a single scan, decreasing the need for repeat scans and thereby minimizing radiation exposure and contrast-media use9.

By providing a fast post-reconstruction option, Motion Freeze streamlines the workflow, allowing the recovery and use of the initial CBCT acquisitions that might otherwise have been discarded10. 
MAR11

Reducing metallic artefacts, optimizing image quality

MAR11 (Metallic Artifact Reduction) is an advanced technology designed to reduce artifacts caused by metal objects in the body, such as implants. These artifacts can indeed obscure important anatomical details, making it difficult for clinicians to accurately diagnose and plan treatments. 

Increasing image quality, MAR11 is a valuable tool for improving the accuracy and safety of minimally-invasive procedures.
Related products

Augmenting CBCT outcomes

Gain confidence and precision when performing CBCT.

Get in touch

Have a question? We would like to hear from you.

REFERENCES
* Product may not be available in all countries. Refer to your sales representatives for more information.
Allia refers to AlliaTM system.

1. Solim LA et al. The efficacy of cone-beam computed tomography-guided transcatheter arterial chemoembolization in hepatocellular carcinoma survival: A systematic review. J Clin Imaging Sci. 2024 ;14:25.

2. Zhong BY et al. Application of Cone-beam Computed Tomography in Interventional Therapies for Liver Malignancy: A Consensus Statement by the Chinese College of Interventionalists. J Clin Transl Hepatol. 2024;12(10):886-891.

3. Designed to be used with AlliaTM systems.

4. CleaRecon DL is an option in 3DXR designed to be used with Allia systems and requires AW workstation with Volume Viewer. May not be available in all countries. Not CE marked.

5. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.

6. The improvement related to Motion Freeze depends on the acquisition conditions, table position, patient, type of motion, anatomical location and clinical practice. 

7. Motion Freeze is an optional feature of 3DXR (part of GE HealthCare vascular systems IGS 5, IGS 6 and IGS 7 or IGS 7OR). Motion Freeze and 3DXR may not be available in all markets. Refer to your sales representative. 

8. Motion Freeze can help salvage CBCT acquisitions by refining and increasing small contrasted structures in CBCT images that would have otherwise been discarded due to involuntary respiratory motion artifacts. 

9. By potentially reducing the need to repeat CBCT acquisitions, Motion Freeze may help minimize radiation dose and contrast media injection. 

10. By helping to salvage, rather than discard, initial CBCT images, Motion Freeze enables access to advanced solutions.

11. MAR is an optional feature of 3DXR, which is included in 3D CT HD, a 3D application of the GE HealthCare vascular system IGS 5, IGS 6, IGS 7 and IGS 7OR, and removes metal artifacts generated by coils in the CBCT field of view. 3D CT HD and MAR may not be available in all markets. Refer your sales representative.

12. 3D CT HD is an option sold separately. Includes 3DXR. Requires AW workstation and Volume Viewer.

13. Product may not be available in all countries. Refer to your sales representative for more information.

14. Embo ASSIST AI solution includes FlightPlan for embolization and requires AW workstation with Volume Viewer, Volume Viewer InnovaTM, Vision 2, VesselIQTM Xpress, AutoBoneTM Xpress. These applications are sold seperatley and may not be available in all countries.

15. Liver ASSIST Virtual Parenchyma solution includes Hepatic VCAR and FlightPlan for Liver with Parenchyma Analysis option and requires AW workstation with Volume Viewer, Volume Viewer Innova, Vision 2, VesselIQ Xpress, AutoBone Xpress. These applications are sold separately. FlightPlan for Liver with Parenchyma Analysis option may not be available for sale in all countries. Please refer to your sales representative for more information. Liver ASSIST Virtual Parenchyma is designed to attain the same performance outcomes of FlightPlan for Liver. The above Liver ASSIST performance outcomes reflect the results of three published journal articles (a,b,c) that used previous version of FlightPlan for Liver software. The results of these published studies do not necessarily represent individual performance of FlightPlan for Liver. a) Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver – Bapst et al. Cardiovasc Intervent Radiol. 2016. b) Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography –Minami et al. Liver Cancer. 2014. c) Clinical utility and limitations of tumor-feeder detection software for liver cancer embolization. Iwazawa et al. European Journal of Radiology. 2013.

JB32974XX